# Trident Toxicology — Form D/A

Trident Toxicology of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2014-10-20. The offering totals $200K, of which $25K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2014-10-20
- Form: D/A
- Accession: 0001621311-14-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $25K
- Remaining: $175K
- Minimum investment: $3K
- Investors: 7
- Date of first sale: 2014-05-16
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-225683

## Issuer

- Name: Trident Toxicology
- CIK: 0001621311
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2013
- Address: 5710 LBJ FREEWAY, DALLAS, TX, 75240
- Phone: 469-888-2258

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Josh James Daniel | Executive Officer | Dallas, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-10-02](https://search.stillhousedata.com/formd/0001621311-14-000001) | D | $200K | $25K |

## More

- [CIK 1621311 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1621311&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001621311-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.